Myriad
Order a GENETIC TESTING KIT
Mutation Prevalence Tables
Hereditary Cancers Genetic Testing Reimbursement/Privacy Resources About Myriad
Melanoma Overview
Identifying Patients
Cancer Risks
Medical Management
Benefits of Testing
Family Matters
FAQs
Search
Site Map
Contact Myriad
Home
Melanoma Cancer Risks

Published Estimates of Cancer Risk for p16 Mutation Carriers

Site Population Risk1 Hereditary Risk
Melanoma
Risk of primary melanoma:

<1% by age 50
~1% by age 80		 Risk of primary melanoma:
50% by age 502
76% by age 802

Risk of second melanomas:
Increased risk for second melanomas in p16 mutation carriers previously diagnosed with one melanoma3,4
15% of patients with multiple primary melanomas (MPM) will have a mutation in the p16 gene4
Pancreatic <1% by age 75
Up to 17% by age 75 in some families5
  1. Ries LAG, Eisner MP, Kosary CL, Hankley BF, Miller BA, Clegg L, Edwards BK (eds). SEER Cancer Statistics Review, 1973-1999, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1973_1999/. Accessed December 30, 2002.
  2. Bishop DT, Demenais F, Goldstein AM, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst. 2002;94:894-903.
  3. Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hannson J. CDKN2A germline mutations in individuals with multiple cutaneous melanomas. Cancer Res. 2000;60:6864-6867.
  4. Monzon J, Liu L, Brill H, et al. CDKN2A mutations in multiple primary melanomas. N Engl J Med. 1998;338:879-887.
  5. Vasen HF, Gruis NA, Frants RR, van Der Velden PA, Hille ET, Bergman W. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer. 2000;87:809-811.

» Managing Patients with Melanoma

MELARIS is a genetic test for hereditary melanoma
A genetic test for hereditary melanoma